Immunogenicity and safety of AZD1222 (ChAdOx1 nCoV-19) against SARS-CoV-2 in Japan: a double-blind, randomized controlled phase 1/2 trial
- Resource Type
- Article
- Source
- In
International Journal of Infectious Diseases January 2022 114:165-174 - Subject
- Language
- ISSN
- 1201-9712